EyePoint Pharmaceuticals, Inc. — Director's Dealing 2019

Jan 29, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EyePoint Pharmaceuticals, Inc. (EYPT)
CIK: 0001314102
Period of Report: 2019-01-25

Reporting Person: GUYER DAVID R (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-01-25	Employee Stock Option (right to buy)	$2.42	A	80000.00	Acquired	2029-01-25	Common Stock (80000.00)	Direct

Footnotes

F1: The option becomes exercisable in three equal annual installments beginning on January 25, 2020.